• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Medivir Initiates Study of Birinapant in Combination with KEYTRUDA americanpharmaceuticalreview
    August 21, 2017
    Medivir announced the first patient has been enrolled in the company's phase I/II study of birinapant in combination with the anti-PD-1 therapy KEYTRUDA (pembrolizumab), which is marketed by MSD. The objectives of the study are to evaluate the safety, tol

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service